Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Vivancos

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|December 29, 2022
Biomarkers of tumor-reactive CD4<sup>+</sup> and CD8<sup>+</sup> TILs associate with improved prognosis in endometrial cancerJara Palomero, Carla Panisello, Maria Lozano-Rabella, et al.
Molecular Oncology|December 20, 2020
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancerJoan Frigola, Alejandro Navarro, Caterina Carbonell, et al.
Molecular Systems Biology|January 23, 2015
Defining a minimal cell: essentiality of small ORFs and ncRNAs in a genome-reduced bacteriumMaria Lluch-Senar, Javier Delgado, Wei-Hua Chen, et al.
Plos Genetics|October 21, 2014
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradationRosaura Esteve-Puig, Rosa Gil, Elena González-Sánchez, et al.
Plos Pathogens|January 23, 2018
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesisFranc Llorens, Katrin Thüne, Eulàlia Martí, et al.
Frontiers in Oncology|November 22, 2021
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 StudySonia Pernas, Patricia Villagrasa, Ana Vivancos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cellsIsabel Puig, Irene Chicote, Stephan P Tenbaum, et al.
Nature Medicine|May 22, 2012
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancerStephan P Tenbaum, Paloma Ordóñez-Morán, Isabel Puig, et al.
Translational Oncology|April 9, 2023
Impact of the COVID-19 pandemic in the early-onset colorectal cancerIosune Baraibar, Ariadna García, Francesc Salvà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine CarcinomasJaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|December 29, 2022
Biomarkers of tumor-reactive CD4<sup>+</sup> and CD8<sup>+</sup> TILs associate with improved prognosis in endometrial cancerJara Palomero, Carla Panisello, Maria Lozano-Rabella, et al.
Molecular Oncology|December 20, 2020
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancerJoan Frigola, Alejandro Navarro, Caterina Carbonell, et al.
Molecular Systems Biology|January 23, 2015
Defining a minimal cell: essentiality of small ORFs and ncRNAs in a genome-reduced bacteriumMaria Lluch-Senar, Javier Delgado, Wei-Hua Chen, et al.
Plos Genetics|October 21, 2014
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradationRosaura Esteve-Puig, Rosa Gil, Elena González-Sánchez, et al.
Plos Pathogens|January 23, 2018
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesisFranc Llorens, Katrin Thüne, Eulàlia Martí, et al.
Frontiers in Oncology|November 22, 2021
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 StudySonia Pernas, Patricia Villagrasa, Ana Vivancos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cellsIsabel Puig, Irene Chicote, Stephan P Tenbaum, et al.
Nature Medicine|May 22, 2012
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancerStephan P Tenbaum, Paloma Ordóñez-Morán, Isabel Puig, et al.
Translational Oncology|April 9, 2023
Impact of the COVID-19 pandemic in the early-onset colorectal cancerIosune Baraibar, Ariadna García, Francesc Salvà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine CarcinomasJaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Pageof 11